股份全流通
Search documents
优地机器人港股IPO及境内未上市股份“全流通”获中国证监会备案
Zhi Tong Cai Jing· 2025-12-02 06:06
12月2日,中国证监会国际合作司发布《关于优地机器人(无锡)股份有限公司境外发行上市及境内未上市股份"全流通"备案通知书》。公司拟发行不超过 73,600,000股境外上市普通股并在香港联合交易所上市。公司33名股东拟将所持合计237,232,625股境内未上市股份转为境外上市股份,并在香港联合交易所 上市流通。 附件:"全流通"股东名称及转换数量 | 序号 | 股东名称 | 申请全流通股数(股) | | --- | --- | --- | | 1 | 北京君联成业股权投资合伙企业(有限合伙) | 29,775,900 | | 2 | 拉扎斯网络科技(上海)有限公司 | 29,342,250 | | 3 | 海南云锋基金中心(有限合伙) | 23,750,650 | | 4 | 九江优地科技产业投资合伙企业(有限合伙) | 21,875,000 | | 5 | 北京新恒基投资管理集团有限公司 | 20,378,050 | | 6 | 武汉众邦鸿翔股权投资合伙企业(有限合伙) | 14,743,050 | | 7 | 重庆冠达控股集团有限公司 | 10,649,800 | | 8 | 扬州市华建诚鼎股权投资合伙 ...
优地机器人境外发行上市及境内未上市股份“全流通”获中国证监会备案
Sou Hu Cai Jing· 2025-12-02 03:56
| 赏 | bm56000001/2025-00013890 | 安 部 | 结果公示;备案管理 | | --- | --- | --- | --- | | 发布机构 | | 发文日期 | 2025年12月02日 | | 名 影 | 关于优地机器人(无锡)股份有限公司境外发行上市及境内未上市股份"全流遗"备案遏知书 | | | | 文 号 | 国合创〔2025〕2129 号 | 主题词 | | 关于优地机器人(无锡)股份有限公司境外发行上市及境内未上市股份"全流通"备案通知书 优地机器人(无锡)股份有限公司: 12月2日,证监会发布《关于优地机器人(无锡)股份有限公司境外发行上市及境内未上市股份"全流 通"备案通知书》。通知提出,该公司拟发行不超过73,600,000股境外上市普通股并在香港联合交易所上 市。该公司33名股东拟将所持合计237.232.625股境内未上市股份转为境外上市股份,并在香港联合交易 所上市流通。 四、你公司完成境外发行上市后15个工作日内,应通过中国证监会各条管理信息系统报告发行上市情况。例公司在境外发行上市及股份转换过 程中应严格遵守境内外有关法律、法规和规则。 五、你公司自本备案 ...
新股消息 | 先通医药港股IPO及境内未上市股份“全流通”获中国证监会备案
智通财经网· 2025-11-28 12:14
Core Viewpoint - The China Securities Regulatory Commission (CSRC) has approved Beijing Xiantong International Pharmaceutical Technology Co., Ltd. to issue up to 9,259,900 overseas listed ordinary shares and to list on the Hong Kong Stock Exchange, along with the conversion of 34,466,214 domestic unlisted shares into overseas listed shares by 95 shareholders [1]. Company Overview - Xiantong Pharmaceutical is a leader in the Chinese radiopharmaceutical market, focusing on the development and commercialization of innovative radiopharmaceuticals with the potential to be the first listed or best-in-class in China [1]. - The company is recognized as the first in China to obtain marketing approval for innovative radiopharmaceuticals, to receive production licensing as a Marketing Authorization Holder (MAH), and to complete clinical trials for therapeutic radioligands accepted by the National Medical Products Administration (NMPA) [1]. Shareholder Participation - A total of 95 shareholders are involved in the conversion of shares, with significant contributions from various investment funds and individuals, including: - Xu Xingsheng: 3,343,071 shares - Jiangsu Jiequan Chengda Equity Investment Center: 2,959,381 shares - Jinshi Manufacturing Transformation and Upgrading New Materials Fund: 2,276,447 shares - China State-Owned Enterprises Structural Adjustment Fund II: 1,707,335 shares [1][2].
百望股份(06657)境内未上市股份“全流通”获中国证监会备案
智通财经网· 2025-09-30 11:41
Core Points - The China Securities Regulatory Commission (CSRC) has issued a notice regarding the "full circulation" registration of unlisted shares for Baiwang Co., Ltd. [1] - A total of 52 shareholders of Baiwang Co., Ltd. plan to convert 135,064,706 shares from unlisted to listed shares for trading on the Hong Kong Stock Exchange [1] - If the share conversion is not completed within 12 months from the issuance of the notice, the company must update its registration materials to continue the process [1] Financial Performance - Baiwang Co., Ltd. reported a revenue of 348 million yuan for the six months ending June 30, 2025, representing a year-on-year increase of 23.45% [4] - The gross profit for the same period was 162 million yuan, showing a year-on-year increase of 46.84% [4] - The company achieved a net profit attributable to shareholders of 3.717 million yuan, a turnaround from a loss of 44.6 million yuan in the same period last year, resulting in a basic earnings per share of 0.02 yuan [4]
港股异动丨云知声逆势大涨超26% 申请股份全流通
Ge Long Hui· 2025-09-11 08:05
Core Viewpoint - The Hong Kong stock market experienced a decline across all major indices, while AI solution provider Yunzhisheng (9678.HK) saw a significant increase of 26.55% to HKD 591 due to its announcement regarding the conversion of non-listed shares to H-shares [1] Company Summary - Yunzhisheng announced that it has submitted an application to the China Securities Regulatory Commission (CSRC) to convert 24,488,277 domestic non-listed shares and 4,570,649 non-listed foreign shares into H-shares [1] - The conversion will allow these shares to be listed and traded on the main board of the Hong Kong Stock Exchange, pending approval from relevant regulatory bodies including the CSRC and the Stock Exchange [1] - As of the announcement date, the company has not yet completed the filing with the CSRC regarding this application and will provide further updates on the progress and details at an appropriate time [1]
云知声申请股份全流通
Zhi Tong Cai Jing· 2025-09-10 12:49
Core Viewpoint - The company Yunzhisheng (09678) has submitted an application to the China Securities Regulatory Commission (CSRC) to convert a total of 24.4883 million domestic unlisted shares and 4.5706 million unlisted foreign shares into H-shares for listing on the Hong Kong Stock Exchange [1] Group 1 - The total number of domestic unlisted shares to be converted is 24.4883 million [1] - The total number of unlisted foreign shares to be converted is 4.5706 million [1] - The conversion is subject to approval from relevant regulatory bodies, including the CSRC and the Hong Kong Stock Exchange [1]
国鸿氢能(09663)境内未上市股份“全流通”获中国证监会备案
智通财经网· 2025-08-26 12:59
Group 1 - The China Securities Regulatory Commission has issued a notification regarding the "full circulation" of unlisted shares for Guohong Hydrogen Energy Technology (Jiaxing) Co., Ltd, allowing 12 shareholders to convert a total of 41,303,978 shares into listed shares on the Hong Kong Stock Exchange [1] - The company must complete the share conversion within 12 months from the date of the notification, or it will need to update its filing materials if it wishes to continue the process [1] Group 2 - According to Frost & Sullivan, the company is a leading player in China's hydrogen fuel cell industry, ranking first in hydrogen fuel cell stack shipments from 2017 to 2022 [4] - The company ranked first in sales value of hydrogen fuel cell systems in 2022 and second in sales volume of hydrogen fuel cell systems in the same year [4]
康宁医院申请股份全流通
Zhi Tong Cai Jing· 2025-08-21 08:47
Core Viewpoint - The company has submitted an application to the China Securities Regulatory Commission (CSRC) to convert 9,286,359 domestic shares into H-shares, pending regulatory approvals [1] Group 1 - The conversion of shares is aimed at allowing the unlisted shares to be traded on the main board of the Stock Exchange of Hong Kong [1] - The company has not yet completed the filing with the CSRC as of the date of the announcement [1]